These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11301190)

  • 21. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.
    Heemskerk MH; Blom B; Nolan G; Stegmann AP; Bakker AQ; Weijer K; Res PC; Spits H
    J Exp Med; 1997 Nov; 186(9):1597-602. PubMed ID: 9348318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.
    McCullar V; Oostendorp R; Panoskaltsis-Mortari A; Yun G; Lutz CT; Wagner JE; Miller JS
    Exp Hematol; 2008 May; 36(5):598-608. PubMed ID: 18295962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
    von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
    Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
    [No Abstract]   [Full Text] [Related]  

  • 24. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells.
    Kunz B; Held W
    J Immunol; 2001 May; 166(10):6181-7. PubMed ID: 11342639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
    Ohkubo T; Bárcena A; Smith CA; Harrison MR; Muench MO
    Fetal Diagn Ther; 2001; 16(5):299-307. PubMed ID: 11509853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD34+CD38dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells.
    Res P; Martínez-Cáceres E; Cristina Jaleco A; Staal F; Noteboom E; Weijer K; Spits H
    Blood; 1996 Jun; 87(12):5196-206. PubMed ID: 8652833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation and limitation of Ly-49A NK cell receptor acquisition by T cell factor-1.
    Ioannidis V; Kunz B; Tanamachi DM; Scarpellino L; Held W
    J Immunol; 2003 Jul; 171(2):769-75. PubMed ID: 12847244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.
    Miller JS; Alley KA; McGlave P
    Blood; 1994 May; 83(9):2594-601. PubMed ID: 7513206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells.
    Huang S; Terstappen LW
    Blood; 1994 Mar; 83(6):1515-26. PubMed ID: 7510144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
    George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
    Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of novel surface antigens on early hematopoietic cells.
    Bühring HJ; Seiffert M; Bock TA; Scheding S; Thiel A; Scheffold A; Kanz L; Brugger W
    Ann N Y Acad Sci; 1999 Apr; 872():25-38; discussion 38-9. PubMed ID: 10372108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.
    Hao QL; Smogorzewska EM; Barsky LW; Crooks GM
    Blood; 1998 Jun; 91(11):4145-51. PubMed ID: 9596660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
    Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
    J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
    Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
    Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic origin of human natural killer (NK) cells: generation from immature progenitors.
    Silva MR; Kessler S; Ascensao JL
    Pathobiology; 1993; 61(5-6):247-55. PubMed ID: 7507682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin.
    Hennemann B; Oh IH; Chuo JY; Kalberer CP; Schley PD; Rose-John S; Humphries RK; Eaves CJ
    Blood; 2000 Oct; 96(7):2432-9. PubMed ID: 11001895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2.
    Ikawa T; Fujimoto S; Kawamoto H; Katsura Y; Yokota Y
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5164-9. PubMed ID: 11296270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.